Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Pozycja w akcjach #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Cena akcji
$19.63
Kapitalizacja rynkowa
$47.10B
Zmiana (1 dzień)
1.80%
Zmiana (1 rok)
-7.33%
Kraj
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategoria

Zyski dla Sun Pharmaceutical Industries Limited (SUNPHARMA)
Zyski w Dec 2025 TTM: $1.64B
Według najnowszych raportów finansowych Sun Pharmaceutical Industries Limited, obecny zysk firmy wynosi $1.64B. W roku 2024 firma osiągnęła zysk w wysokości $1.33B, wzrost w porównaniu do zysku z roku 2023, który wynosił $1.14B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Sun Pharmaceutical Industries Limited od 2004 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $1.64B 2.22%
2025 $1.61B 21.21%
2024 $1.33B 16.34%
2023 $1.14B 93.65%
2022 $588.17M 54.49%
2021 $380.72M -42.58%
2020 $663.01M 20.88%
2019 $548.49M 3.41%
2018 $530.42M -62.03%
2017 $1.40B 40.80%
2016 $992.01M -3.13%
2015 $1.02B 33.99%
2014 $764.30M -3.90%
2013 $795.33M 20.15%
2012 $661.93M 44.90%
2011 $456.82M 45.01%
2010 $315.02M -17.95%
2009 $383.94M -3.94%
2008 $399.69M 107.87%
2007 $192.27M 43.47%
2006 $134.02M 39.03%
2005 $96.39M 9.76%
2004 $87.82M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$651.61M -60.31%
FR
$3.88B 136.40%
DE
$1.32B -19.32%
JP
$3.36B 104.66%
US
$4.84B 194.62%
GB